Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Cesari

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cells|July 11, 2025
Modulation of Neurexins Alternative Splicing by Cannabinoid Receptors 1 (CB1) SignalingElisa Innocenzi, Giuseppe Sciamanna, Alice Zucchi, et al.
Experimental Neurology|October 15, 2020
Alternative splicing of neurexins 1-3 is modulated by neuroinflammation in the prefrontal cortex of a murine model of multiple sclerosisElisa Marchese, Mariagrazia Valentini, Gabriele Di Sante, et al.
Frontiers in Cellular Neuroscience|November 13, 2018
The Neuroprotective Effects of 17β-Estradiol Pretreatment in a Model of Neonatal Hippocampal Injury Induced by TrimethyltinElisa Marchese, Valentina Corvino, Valentina Di Maria, et al.
Cell Reports|September 14, 2024
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancerCinzia Caggiano, Valerio Petrera, Miriana Ferri, et al.
Cell Death and Differentiation|September 28, 2018
The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29Elisabetta Volpe, Eleonora Cesari, Neri Mercatelli, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 11, 2026
Single-cell transcriptome analysis of patient-derived organoids captures inter- and intratumor heterogeneity and uncovers targetable pathways in high grade serous ovarian cancerMarco Pieraccioli, Alessandra Ciucci, Christian Corti, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2026
Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancerIrene Taddei, Claudia Cirotti, Fabienne Lamballe, et al.
Cancer Communications (London, England)|December 16, 2023
Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3Bianca Cesaro, Alessia Iaiza, Fabio Piscopo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 18, 2023
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoidsEleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, et al.
Cell Reports|June 4, 2020
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing CerebellumDonatella Farini, Eleonora Cesari, Robert J Weatheritt, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cells|July 11, 2025
Modulation of Neurexins Alternative Splicing by Cannabinoid Receptors 1 (CB1) SignalingElisa Innocenzi, Giuseppe Sciamanna, Alice Zucchi, et al.
Experimental Neurology|October 15, 2020
Alternative splicing of neurexins 1-3 is modulated by neuroinflammation in the prefrontal cortex of a murine model of multiple sclerosisElisa Marchese, Mariagrazia Valentini, Gabriele Di Sante, et al.
Frontiers in Cellular Neuroscience|November 13, 2018
The Neuroprotective Effects of 17β-Estradiol Pretreatment in a Model of Neonatal Hippocampal Injury Induced by TrimethyltinElisa Marchese, Valentina Corvino, Valentina Di Maria, et al.
Cell Reports|September 14, 2024
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancerCinzia Caggiano, Valerio Petrera, Miriana Ferri, et al.
Cell Death and Differentiation|September 28, 2018
The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29Elisabetta Volpe, Eleonora Cesari, Neri Mercatelli, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 11, 2026
Single-cell transcriptome analysis of patient-derived organoids captures inter- and intratumor heterogeneity and uncovers targetable pathways in high grade serous ovarian cancerMarco Pieraccioli, Alessandra Ciucci, Christian Corti, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2026
Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancerIrene Taddei, Claudia Cirotti, Fabienne Lamballe, et al.
Cancer Communications (London, England)|December 16, 2023
Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3Bianca Cesaro, Alessia Iaiza, Fabio Piscopo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 18, 2023
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoidsEleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, et al.
Cell Reports|June 4, 2020
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing CerebellumDonatella Farini, Eleonora Cesari, Robert J Weatheritt, et al.
Pageof 3